Assessment of Cardiovascular Risk – The Impact and Future of Non-traditional Cardiovascular Risk Markers
In relatively young patients (men <55 and women >65 years of age), first-time hospitalisation for cardiovascular disease (CVD) strikes without warning since the traditional cardiovascular risk factors are often normal or only slightly elevated. Therefore, we need non-traditional cardiovascular risk markers more closely related to CVD that can reliably predict future CVD in individuals, making better targeted prevention and more individualised treatment possible. However, it has been difficult to find non-traditional cardiovascular risk markers suitable for risk assessment, underlining the importance of future research into the complex mechanisms that lead to CVD. Better understanding of these complex mechanisms might enable us to find better risk markers and improve future cardiovascular risk assessment and treatment.